Literature DB >> 7622221

Functional capacities of clonal antibodies to Haemophilus influenzae type b polysaccharide.

M H Nahm1, K H Kim, P Anderson, S V Hetherington, M K Park.   

Abstract

Haemophilus influenzae type b (Hib) is an important pathogen for young children, and children can be protected with antibodies (Abs) to Hib polysaccharide (PS) capsule, a linear polymer of ribosyl ribitol phosphate. The structure of anti-Hib-PS Abs has been well characterized at the molecular level; about two-thirds of anti-Hib-PS Abs use a V kappa gene named A2, and the remaining anti-Hib-PS Abs use one of many other VL genes. In order to understand the structural basis for the variability in the function of these Abs, we prepared 18 clonally pure Abs from adults and studied their affinity, avidity, bactericidal potency in vitro, and ability to reduce bacteremia in newborn rats. Affinities and avidities were determined as the inverse of the concentrations of short (3 repeating units) and long (20 repeating units) ligands which could bind 50% of anti-Hib-PS Ab in solution, respectively. No significant correlations between the protection of newborn rats and affinity (r = 0.02) or avidity (r = 0.16) were observed. The amount of Ab required to kill 50% of bacteria in vitro decreased with avidity (r = -0.32), as expected. However, Abs with high affinity were unexpectedly found to have less bactericidal activity (r = 0.38). This suggests that avidity may be a better predictor of Ab function than affinity. Affinity and avidity results were negatively correlated (r = 0.76, P = 0.0022), and Abs that had A2 V kappa gene products had higher avidity (P < 0.05) and lower affinity (P = 0.06) than Abs that had other VL genes. A possible explanation of these observations is that the epitope for Abs with the A2 gene is within the Hib-PS chain itself, whereas the epitope for Abs with a non-A2 gene is the terminus of Hib-PS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622221      PMCID: PMC173406          DOI: 10.1128/iai.63.8.2989-2994.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Analysis of junctional diversity during B lymphocyte development.

Authors:  K Meek
Journal:  Science       Date:  1990-11-09       Impact factor: 47.728

2.  Solid phase disruption of fluid phase equilibrium in affinity assays with ELISA.

Authors:  S Hetherington
Journal:  J Immunol Methods       Date:  1990-08-07       Impact factor: 2.303

3.  Variability in the functional activity of vaccine-induced antibody to Haemophilus influenzae type b.

Authors:  J Amir; X Liang; D M Granoff
Journal:  Pediatr Res       Date:  1990-04       Impact factor: 3.756

4.  Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. III. A single VKII gene and one of several JK genes are joined by an invariant arginine to form the most common L chain V region.

Authors:  M G Scott; D L Crimmins; D W McCourt; I Zocher; R Thiebe; H G Zachau; M H Nahm
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

5.  Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. II. IgG antibodies contain VH genes from a single VH family and VL genes from at least four VL families.

Authors:  M G Scott; J J Tarrand; D L Crimmins; D W McCourt; N R Siegel; C E Smith; M H Nahm
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

6.  The effects of subclass on the ability of anti-phosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae.

Authors:  D E Briles; C Forman; S Hudak; J L Claflin
Journal:  J Mol Cell Immunol       Date:  1984

7.  Distinct pattern of antibody reactivity with oligomeric or polymeric forms of the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  S Pillai; S Ciciriello; M Koster; R Eby
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

8.  Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b.

Authors:  J Amir; M G Scott; M H Nahm; D M Granoff
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

9.  Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type B polysaccharide. Demonstration of three types of V regions and their association with H and L chain isotypes.

Authors:  J J Tarrand; M G Scott; P A Takes; M H Nahm
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

10.  Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences.

Authors:  A J Feeney
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

View more
  9 in total

1.  Structural requirements of the major protective antibody to Haemophilus influenzae type b.

Authors:  L Hougs; L Juul; A Svejgaard; T Barington
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.

Authors:  Nina Ekström; Heidi Ahman; Jouko Verho; Jukka Jokinen; Merja Väkeväinen; Terhi Kilpi; Helena Käyhty
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Immunoglobulin allotypes and immunoglobulin G subclass responses to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in early-onset periodontitis.

Authors:  J I Choi; M H Ha; J H Kim; S J Kim
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

4.  Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.

Authors:  M A Julie Westerink; Harry W Schroeder; Moon H Nahm
Journal:  Aging Dis       Date:  2011-07-20       Impact factor: 6.745

5.  Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.

Authors:  Nina Ekström; Merja Väkeväinen; Jouko Verho; Terhi Kilpi; Helena Käyhty
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

6.  Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F.

Authors:  A H Lucas; D M Granoff; R E Mandrell; C C Connolly; A S Shan; D C Powers
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable heavy chain repertoire.

Authors:  Kris Kolibab; S Louise Smithson; Bradley Rabquer; Sadik Khuder; M A Julie Westerink
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

8.  The V-region repertoire of Haemophilus influenzae type b polysaccharide antibodies induced by immunization of infants.

Authors:  G H Chung; K H Kim; R S Daum; R A Insel; G R Siber; S Sood; R K Gupta; C Marchant; M H Nahm
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Immunoglobulin G avidities in infants in Mexico after primary immunization with three doses of polyribosylribitol phosphate-tetanus toxoid Haemophilus influenzae type b vaccine.

Authors:  Patricia Gómez-de-León; F Javier Díaz-García; Alberto Villaseñor-Sierra; Jorge Segura; Martha I Carranza; José Luis Arredondo-Garcia; José Ignacio Santos
Journal:  Clin Vaccine Immunol       Date:  2008-04-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.